Edition:
India

Ibnsina Pharma Co (ISPH.CA)

ISPH.CA on The Egyptian Exchange

9.25EGP
14 Jul 2019
Change (% chg)

£0.02 (+0.22%)
Prev Close
£9.23
Open
£9.00
Day's High
£9.44
Day's Low
£9.00
Volume
2,712,396
Avg. Vol
541,676
52-wk High
£11.97
52-wk Low
£6.52

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 3,726.35 0.050
FY 2018 Dec '18 3,890.29 0.090
Sep '18 3,482.53 0.141
Jun '18 3,069.76 0.062
Mar '18 2,881.10 0.036
FY 2017 Dec '17 2,871.13 0.035
Sep '17 2,639.82 0.117
Jun '17 2,168.65 0.044
Mar '17 1,906.75 0.025
 
*Note: Units in Millions ofEgyptian Pound
**Note: Units in Egyptian Pound

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 4 17,100.50 17,792.00 16,418.00 15,172.50
Year Ending Dec-20 5 21,263.60 23,245.00 19,807.00 18,668.00
Earnings (per share)
Year Ending Dec-19 4 0.39 0.50 0.18 0.51
Year Ending Dec-20 5 0.58 0.70 0.35 0.71
Sales and Profit Figures in Egypt Pound (EGP);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.88 32.67
P/E High - Last 5 Yrs. -- 42.96 47.29
P/E Low - Last 5 Yrs. -- 23.36 23.87
Beta -- 0.89 0.89
Price to Sales (TTM) -- 6.26 7.92
Price to Book (MRQ) -- 5.26 5.39
Price to Tangible Book (MRQ) -- 5.93 6.71
Price to Cash Flow (TTM) -- 23.51 24.37
% Owned Institutions -- 0.75 1.45

Dividends

  Company industry sector
Dividend Yield -- 1.42 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.38
Dividend 5 Year Growth Rate -- 3.90 4.54
Payout Ratio(TTM) -- 42.61 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.12 12.24
Sales (TTM) vs TTM 1 Yr. Ago -- 6.49 7.75
Sales - 5 Yr. Growth Rate -- 10.59 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 40.64 43.00
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.80 10.33
Capital Spending - 5 Yr. Growth Rate -- 15.44 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.21
Current Ratio (MRQ) -- 2.93 3.03
LT Debt to Equity (MRQ) -- 7.95 10.21
Total Debt to Equity (MRQ) -- 11.65 14.57
Interest Coverage (TTM) -- 32.88 29.24

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.83 52.21
Gross Margin - 5 Yr. Avg. -- 49.67 50.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.40 13.16
Operating Margin (TTM) -- 13.79 6.89
Operating Margin - 5 Yr. Avg. -- 13.96 8.97
Pre-Tax Margin (TTM) -- 12.42 6.09
Pre-Tax Margin - 5 Yr. Avg. -- 14.37 9.26
Net Profit Margin (TTM) -- 9.21 2.72
Net Profit Margin - 5 Yr. Avg. -- 10.80 5.63
Effective Tax Rate (TTM) -- 22.44 22.40
Effective Tax Rate - 5 Yr. Avg. -- 22.49 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 993,588,171 887,658,316
Net Income/Employee (TTM) -- 114,088,254 101,887,456
Receivable Turnover (TTM) -- 5.96 5.94
Inventory Turnover (TTM) -- 2.62 3.36
Asset Turnover (TTM) -- 0.97 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.51 11.18
Return on Assets - 5 Yr. Avg. -- 12.96 12.34
Return on Investment (TTM) -- 14.90 14.49
Return on Investment - 5 Yr. Avg. -- 16.86 16.03
Return on Equity (TTM) -- 16.02 15.79
Return on Equity - 5 Yr. Avg. -- 17.66 17.01
Note: Units in Millions of US Dollars

Performance for Ibnsina Pharma Co

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 17.72%
# of Holders: 16
Total Shares Held: 145,304,564
3 Mo. Net Change: -3,365,421
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 0
# Reduced Positions: 3
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.